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Abstract
The prevalence of chronic medical and psychiatric diseases has continued to
increase worldwide, and their consequences have remained a growing concern. Acting
with a number of sociodemographic and clinical variables, they tend to affect quality of
life (QOL) and onward to life expectancy. There is a direct relationship between QOL
and life expectancy. Hypertension and diabetes mellitus acting with adverse environ-
mental factors reset and overamplify the sympathetic outflow, and this may worsen
hypertension and or cause depression, dysthymia, and anxiety disorders. Tuberculosis
and HIV are two chronic infective medical conditions that equally negatively affect
quality of life well-being and life expectancy. These chronic medical and psychiatric
conditions have been associatedwith reducedQOL and life expectancy. The aim of this
study, therefore, was to determine the impact of chronic medical and psychiatric
disorders (HIV, tuberculosis, diabetes mellitus, hypertension, dysthymia, and GAD)
on quality of life and life expectancy. Following ethical approval and informed consent
from the participants, 40 subjects from each group of HIV, tuberculosis, diabetes
mellitus, hypertension, anxiety, and dysthymia were studied using sociodemographic/
clinical questionnaire and theWHOQOL-Bref. The data were analyzed using the SPSS
version 20 statistical package. Confidence interval was set at 95%while P-value of less
than 0.05 was considered statistically significant. There was reduced QOL on physical,
psychological, and social relationship, environment domains, and general health facet,
respectively. Chronic medical and psychiatric conditions may contribute to reduced
QOL and life expectancy. Management of patients with these conditions should neces-
sarily include attention to their QOL andwell-being.
Keywords: chronic medical and psychiatric diseases, QOL, life expectancy, UPTH
1. Introduction
The prevalence of chronic medical and psychiatric diseases has continued to
increase worldwide, and their consequences have remained a growing concern.
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Acting with a number of sociodemographic and clinical variables, they tend to nega-
tively affect life expectancy through, among many other pathways, reducing quality
of life. Despite healthcare improvements, there has been little evidence of benefit on
life expectancy in people with chronic medical and mental disorders [1–3].
A number of sociodemographic and clinical variables may however serve as key
determinants of quality of life and life expectancy. In Nigeria, these medical condi-
tions have remained on the rise [4–9]. Studies have noted a prevalence of 10–15%
for diabetes mellitus and 4.6% for HIV infection [4–6]. Worldwide, it was esti-
mated that diabetes affected 285 million adults (20–79 years) in 2010, and this
figure would likely increase to about 439 million adults by 2030 [6]. The World
Health Organization (WHO) has also estimated that 2 billion people, almost a third
of the world’s population, have latent TB [7–9] which is one of the leading causes of
mortality worldwide [9–11]. About 8 million people develop tuberculosis every
year, and out of this number, some 3 million die of it, and over 95% are from
developing countries [9–11].
The global prevalence of high blood pressures has been estimated to be between
10 and 15% of adult populations [12], which is also in line with the findings in Africa
[13]. However, other studies have reported a worldwide prevalence of 15–30% in
adults [14]. The prevalence of hypertension has increased from 11.2% in 1990 to
27.9% in 2010 in rural communities in the Niger Delta and 44.3% in urban Lagos
[15–17]. Over 36 million people have contracted HIV infection worldwide, and over
16 million people are said to have died from the disease [4, 11]. The prevalence of
cancer diseases, schizophrenia, and dementia have all continued to increase [18–21].
In terms of mode of acquisition, while hypertension, diabetes mellitus, cancer,
schizophrenia, and dementia have a clear genetic component, in addition to adverse
environmental factors [22, 23], HIV and tuberculosis are mainly acquired infections
[24–26]. Furthermore, HIV infection, tuberculosis, and schizophrenia are associ-
ated with a high level of stigma and social discrimination [26–29], another strong
determinant of the degree of psychological impact of these chronic conditions. It is
also worthy of note that while severe emotional trauma can directly cause hyper-
tension, diabetes, and schizophrenia [30–32], it can only predispose an individual to
acquiring HIV due to poor sense of judgment, leading to sexual indiscretion and
other risk-bearing practices [24–26]. In their late stages, HIV and tuberculosis
infections can also cause dementia and mental disorders including schizophrenia-
like illnesses [33–37].
The choice for their comparison was basically borne out of the observation that
they all share some common features in terms of chronicity, with subsequent need
for long-term medications, direct or indirect effects on the central nervous system
(CNS) [25], high rate of mortality [18–21] and morbidity [32–38], and impact on
emotion [33–38]. In addition, patients with these conditions need extensive educa-
tion, attitudinal change, and coping and healthy lifestyle including diet and exercise
[39–42]. The illnesses are equally similar in terms of complications in the central
nervous system [21, 23]. Diabetic ketoacidosis, HIV and hypertensive encephalopa-
thies, CNS disseminated tuberculosis, some metastasis to the brain cells, as well
as the direct CNS impairment may all directly or indirectly affect the brain cell
functions and cognitive ability. This in turn may cause altered sensorium, neuro-
affections, neuro-deficits, cognitive impairment, and seizures in some cases. Fur-
thermore, all conditions can directly alter neurotransmitter levels due to direct toxic
effects on the brain cells (neurons) either from the viral cells or other opportunistic
infections, disseminated tuberculosis to the CNS, hypertensive encephalopathy, or
ketoacidotic complication, significantly disrupting relevant neurotransmissions.
This may affect particularly the limbic apparatus, the center that regulates mood
and controls emotions, anger, and rage.
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It is equally important to note that baseline adverse psychosocial factors or
psychological distress have been implicated as predictors of schizophrenia, hyper-
tension and diabetes, or HIV infection [9–12, 43], through impairment of judgment
in the later [24–26]. Also, certain environmental as well as socioeconomic factors
have been identified to predispose to tuberculosis like living in an overcrowded
environment [9–12, 43].
Studies have indicated that life expectancy decreases with each additional
chronic condition [1–3]. A study remarked that a 67-year-old person will live on
average 22.6 additional years in the absence of any chronic conditions while a
67-year-old person will live 7.7 fewer years and 17.6 fewer years with 5 chronic
conditions and ≥10 chronic conditions, respectively [44]. The same study found
that the average marginal decline in life expectancy was 1.8 years with each addi-
tional chronic condition ranging from 0.4 fewer years with the first condition to
2.6 fewer years with the sixth condition. These results are consistent by sex and
race [44].
Another study using a sample of Medicare beneficiaries enrolled as of
January 2008, of 21 different chronic conditions and about 1.4 million persons
aged 67 and above, found that, on average, a 75-year-old American woman who
has no chronic conditions will live 17.3 additional years to more than 92 years
old [45]. Conversely, similar individual with five chronic conditions will live, on
average, only to age 87, while an individual with 10 or more chronic conditions
will survive only to age 80 [45]. Women tend to live longer than men, while
white people live longer than black. Clearly, the nature and number of the
chronic diseases are important for life expectancy. An individual with heart disease
at age 67 is estimated to live an additional 21.2 years on average, while someone of
the same age diagnosed with Alzheimer’s disease is only expected to live 12 addi-
tional years [46]. Different medical conditions have different life expectancy,
but this difference gradually decreases with age and more comorbid conditions
[44–49].
Struggling with multiple chronic illnesses shortens life expectancy dramatically
[45–49], and for older individuals, chronic or multiple chronic conditions equally
threaten to reverse recent gains in average life spans. The medical advances and
new technologies that have allowed sick people to live longer may not be able to
keep up with the growing burden of chronic diseases. It is becoming very clear
that preventing the development of additional chronic conditions and giving
adequate treatment when they occur in the middle ages and the elderly could be the
only way to continue to improve life expectancy. Violence and adverse childhood
events are said to speed up aging, and life span continues to increase with each
generation.
Concerns about premature mortality among people with chronic mental and
medical disorders have been increasing [1–3]. Higher general and specific causes of
mortality in all or specific age groups have been identified for people with serious
medical and mental illnesses [18–21]. People with chronic and severe mental
illness have lower life expectancies of between 13 and more than 30 years than
the general population [50], and a loss of 8.8 life years (14.1 years for men and
5.7 years for women) was estimated by a study which compared people treated
for SMI and the general population in Massachusetts, USA [2]. Also, using a
nationwide hospital discharge registry, a study reported a wide difference in life
expectancy at age 30 for the main mental disorder categories compared to the
general population, particularly for functional psychosis other than schizophrenia/
affective psychosis (15.9 years lost), substance abuse (15.6 years lost), and
organic psychosis (14.8 years lost) for men and organic psychosis (22.6 years lost),
mental retardation (14.7 years lost), and substance abuse (18.8 years lost) for
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women [46]. Emphasis has been made on management of suicide risk and physical
illness, minimum polypharmacy, and improvement of accessibility to physical
healthcare [51].
Social security and different forms of life insurance policies have greatly helped
in stabilizing life expectancy; in spite of this, a growing number of beneficiaries
with multiple chronic conditions still have reduced life expectancy. The burden and
stress of chronic disease could erase decades of progress. Life expectancy in the USA
is rising more slowly than in other parts of the developed world. Many blame the
obesity epidemic and related health conditions for the worsening health of the
American population.
Functional limitations, including difficulty walking across the room or preparing
meals, and health problems, such as high blood pressure, cancer, and diabetes, also
predicted greater odds of experiencing a fall for adults 65 and older. Previous
research indicates that older African Americans were more likely to live in extended
family households. The availability of assistance at home could help older adults
avoid scenarios or behaviors that could lead to falls.
Medication side effect is another important factor influencing longevity [51–57].
People with chronic illness tend to stay compliant longer on medications with less
side effect profiles. For example, many people living with HIV find it difficult to
continue the treatment regimen due to the side effects [53, 58]. Hence, decreasing
the toxicity and side effects of HIV drugs will increase longevity, as this will
increase their life span by increasing the amount of time that patients can stay on
the life-saving treatment regimen and also increase quality of life [52–54]. Similarly,
the antituberculosis and anticancer drugs are known to have serious side effects that
can impair drug compliance, thereby reducing the life span of the affected individ-
ual [55–57, 59–62]. Bringing new drugs to market is an essential part of increasing
the life expectancy of young people with HIV, but lowering the drugs’ toxicity may
have even greater health benefits for all HIV patients [52, 54]. Some side effects,
such as increased cardiovascular risk, also cause problems that directly contribute to
premature mortality and reduced life.
In spite of the current drug toxicity levels, young people with HIV add nearly
2 years to their lives by initiating HIV treatment regimens soon after infection [52].
If a new drug has a low toxicity and is well-tolerated by the patients, then they are
more likely to take it regularly so that it is as effective as possible, and this will add
to their life span. Reduction in the toxicity of new drugs has been associated with
increase in the patient’s quality-adjusted life expectancy by as much as 11%, or more
than 3 years [52]. “Quality-adjusted life years” and “quality-adjusted life expec-
tancy” are measures that are used to determine the value of different medical
actions. For example, a potentially life-saving drug that is highly toxic, causes so
much discomfort, and leaves a patient debilitated would have a lower value than a
life-saving drug that does not have such side effects. Furthermore, there exists the
negative psychological impact of being on medications for a long time (and in some
cases a lifetime), which is in turn detrimental on quality of life and longevity.
Infectious diseases are a significant health concern especially in developing coun-
tries, and this has significantly contributed to life expectancy [24–29]. Of particular
importance is the interface between the immune system and invading bacteria or
virus and the proteins that protrude through the outer cell membrane of the bacteria
or virus. Because these outer membrane proteins are on the outside of the antigenic
cells, they are visible to the human immune system and therefore are targeted by
antibodies. Antibodies are so tuned to recognize the three-dimensional structure of
outer membrane proteins that they can attach to them with lock-and-key specificity,
thereby labeling the foreign bacteria cell for elimination.
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Mutations in the genes that code for outer membrane proteins can produce
changes in the protein’s structure, and if the key then no longer fits the lock,
the genetic mutations allow the bacterium or virus to evade recognition by
antibodies [9, 25, 29]. The intense selective pressure on the disease-causing
microorganism to survive the immune response, coupled with increased
mutation rates, produces the incredibly fast rate of genomic change in infectious
organisms. Mutations occur randomly throughout the genome, but because they
help the microorganism avoid elimination by the immune system, changes in
outer membrane proteins appear much more often than would be expected by
chance in the surviving organism. Furthermore, this initial burst of mutations
during the acute phase of infection allows the bacteria or virus to survive the
host’s immune response, and this helps to establish a chronic infection
including HIV and tuberculosis. In addition, the already weakened or compromised
immunity sets a vulnerable pace for repeated reinfections or other new
infections [24–29]. These infections eventually become chronic and invariably
affect longevity.
The chronicity of these medical illnesses, persistent and recurrent symptoms,
impairment in functioning capacity, other adverse and enduring environmental
psychosocial burdens, and even the thought of these can also in turn affect quality
of life and subsequently lower life expectancy. Although HIV- and tuberculosis-
infected and cancer-affected patients under antiretroviral (arbacire, nevirapine),
antituberculosis drug (isoniazid and cycloserine), and anticancer medication
(methotrexate) therapy infrequently suffer acute organic psychotic complications,
the chronicity of the disease places them at greater risk for psychiatric comorbidity
than the general population [63–77].
The terms “quality of life” refers to the physical, psychological, and social
domains of health, viewed as distinct areas that are influenced by a person’s experi-
ences, beliefs, expectations, and perception [78], (“which is referred to here collec-
tively as perceptions of health”). Two things are significant in the above definition:
the first is the subjective nature of QOL, and second is the need for a Clinician to
assess all those areas of life considered as having significant impact on QOL. Quality
of life assessment measures changes in physical, functional, mental, and social
health in order to evaluate the human and financial cost and benefits of new
programs and interventions [78, 79].
Quality of life therefore is impaired in many ways by the individual’s level of
independence, social relationships, personal beliefs, and their relationship to salient
features of the environment in addition to their physical health and psychological
state. Quality of life also consists of fulfilling needs, meeting of social expectations,
and assessing opportunities by using abilities. Abilities are impaired by ill health
and worse still chronic medical illnesses [78, 79]. The services rendered by
healthcare givers in mental health help to moderate social demands, supplement
opportunities, and restore abilities. Quality of life can be altered by both the imme-
diate and the long-term consequences of treatment especially the case of chronic
illnesses [80]. Since 1948, when the WHO defined health as being not only the
absence of disease and infirmity but also the presence of physical, mental, and social
well-being, quality-of-life issues and well-being have taken the center stage in
healthcare practices and research [78, 79, 81]. Several studies have shown that
chronic medical and mental illnesses often impair or have negative impacts on the
quality of life and subjective well-being of persons across a whole range of areas
[80, 82–89].
There has been a growing interest during the past decades for assessing deter-
minant factors of patients’ health-related quality of life (HRQOL), especially in
5
Impact of Chronic Medical and Neuropsychiatric Illnesses on Quality of Life and Life…
DOI: http://dx.doi.org/10.5772/intechopen.90756
chronic diseases [78–89]. Diabetes mellitus, HIV, tuberculosis, hypertensive, can-
cer, schizophrenia, and dementia are some of these chronic diseases that involve
people of all races and to some extent all ages. They are considered common chronic
diseases in most countries, and their prevalence has continued to increase. Several
studies have shown that chronic illnesses often impair or have negative impacts on
the quality of life and subjective well-being of persons across a whole range of areas
[80, 82–89].
Tuberculosis, HIV, and cancer diseases weaken patients’ physical functioning
and impair their quality of life and hence may affect life expectancy [82–85]. It has
become important that TB and HIV control programs as well as cancer awareness
and prevention programs at public health clinics design strategies to improve the
quality of health and life of these patients. In patients with chronic diseases, all
predicted domains of quality of life (QOL), including general health perceptions,
somatic sensation, psychological health, spiritual well-being, and physical, social,
and role functioning, all tend to be negatively affected [86-93]. Social stigmatiza-
tion, isolation, pill burden, long duration of therapy, sexual dysfunction, loss of
income, and fear were additional specific problems related to chronic medical
conditions [80, 82–88]. Despite available curative therapy, TB and its treatment
still have significant short- and long-term consequences on patients’ QOL
[82, 83, 86–93]. QOL has also been characterized as “the ultimate goal of all health
interventions” [81].
2. Aim
The aim of this study, therefore, was to determine the impact of chronic medical
and neuropsychiatric disorders (HIV, tuberculosis, diabetes mellitus, hypertension,
schizophrenia, and dementia) on life expectancy and the role of quality of life and
well-being.
3. Methodology
Following ethical approval and informed consent from the participants,
20 subjects from each group of HIV, tuberculosis, diabetes mellitus, hypertension,
schizophrenia, and dementia were recruited based on the study’s inclusion and
exclusion criteria. The study group comprised patients already diagnosed by the
consultant physicians at their respective specialty clinics at the University of Port
Harcourt Teaching Hospital and on treatment and have been regular on follow-up
at their respective outpatient clinics. Participants were recruited through a simple
random sampling. Those recruited were within 30–40 years of age, whose illness
duration was within 3–5 years. Thirty-five normal individuals (five for each medical
condition) were selected also via simple random sampling from among staff of the
hospital, matched for age and sex, as controls.
Both subjects and controls were administered the study’s instruments
including the sociodemographic/clinical questionnaire, WHO Composite
International Diagnostic Interview (WHO CIDI), and the WHOQOL-Bref.
The data were analyzed using the SPSS version 20 statistical package.
The cohorts and control were followed up for clinic attendance, dropout,
quality of life, death, and survival rates after 5 years. Confidence interval was
set at 95%, while P-value of less than 0.05 was considered statistically significant
(Tables 1 and 2).
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4. Results
Variable DM Hypertension HIV TB Cancer Schizo Dementia
Age
30–39 years 9 (45%) 6 (30%) 12 (60%) 9 (45%) 7 (35%) 11 (55%) 0 (0%)
40–49 years 11 (55%) 14 (70%) 8 (40%) 11 (55%) 13 (65%) 9 (45%) 20 (100%)
Sex
Female 12 (60%) 10 (50%) 10 (50%) 9 (45%) 10 (50%) 12 (60%) 11 (55%)
Male 8 (40%) 10 (50%) 10 (50%) 11 (55%) 10 (50%) 8 (40%) 9 (54%)
Marital status
Married 10 (50%) 8 (40%) 8 (40%) 9 (45%) 12 (60%) 6 (30%) 14 (70%)
Divorce 2 (10%) 1 (5%) 2 (10%) 3 (15%) 2 (10%) 0 (0%) 0 (0%)
Separated 3 (15%) 3 (15%) 3 (15%) 3 (15%) 1 (5%) 5 (25%) 3 (15%)
Single 3 (15%) 4 (20%) 6 (30%) 4 (20%) 3 (15%) 9 (45%) 1 (5%)
Widowed 2 (10%) 4 (20%) 1 (5%) 1 (5%) 1 (5%) 0 (0%) 2 (10%)
Education
Primary 2 (10%) 3 (15%) 3 (15%) 3 (15%) 2 (10%) 2 (10%) 2 (10%)
Secondary 8 (40%) 7 (35%) 4 (20%) 7 (35%) 6 (30%) 10 (50%) 5 (25%)
Tertiary 9 (45%) 8 (40%) 7 (35%) 7 (35%) 11 (55%) 7 (35%) 13 (65%)
None 1 (5%) 2 (10%) 1 (5%) 3 (15%) 0 (0%) 1 (5%) 0 (0%)
Occupation
Managers 2 (10%) 1 (5%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 3 (15%)
Professionals 3 (15%) 1 (5%) 1 (5%) 0 (0%) 4 (20%) 0 (0%) 4 (20%)
Clerical support
workers
5 (25%) 5 (25%) 4 (20%) 5 (25%) 4 (20%) 0 (0%) 2 (10%)
Service and sales
workers
2 (10%) 4 (20%) 4 (20%) 5 (25%) 3 (15%) 3 (15%) 3 (15%)
Skilled agricultural
forestry and fishery
workers
4 (20%) 5 (25%) 2 (10%) 4 (20%) 2 (10%) 4 (20%) 2 (10%)
Craft and related
trade workers
2 (10%) 1 (5%) 4 (20%) 3 (15%) 3 (15%) 4 (20%) 2 (10%)
Plant and machine
operators and
assemblers
1 (5%) 1 (5%) 3 (15%) 1 (5%) 2 (10%) 3 (15%) 1 (5%)
Elementary
occupation
1 (5%) 1 (5%) 2 (10%) 2 (10%) 2 (10%) 6 (30%) 1 (5%)
Armed forces
occupation
0 (0%) 1 (5%) 1 (5%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Income
Low 5 (25%) 4 (20%) 8 (40%) 9 (45%) 6 (30%) 11 (55%) 7 (35%)
Average 13 (65%) 14 (70%) 11 (55%) 10 (50%) 18 (90%) 9 (45%) 6 (30%)
High 2 (10%) 2 (10%) 1 (5%) 1 (5%) 1 (5%) 0 (0%) 7 (35%)
Table 1.
Sociodemographic variables of patients with diabetes, hypertension, HIV, tuberculosis, cancer schizophrenia,
and dementia.
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Medical/mental condition Respondents Domains of quality of life
Domain 1 (physical) Domain 2 (psychological) Domain 3 (social relationship) Domain 4 (environment) GHF
DM Control 51.97  14.77 56.20  22.19 57.51  26.13 52.01  16.91 48.34  22.44
Subjects 44.98  13.064 56.60  24.914 48.06  26.114 44.95  14.831 47.98  21.896
Hypertension Subjects 45.98.  13.064 46.60  24.914 53.06  26.114 56.95  14.831 50.98  21.896
Control 60.46  12.788 61.05  13.362 66.80  21.378 59.62  16.503 51.91  23.319
HIV Subjects 53.70  10.103 48.67  15.016 46.84  21.032 50.33  10.456 63.83  20.349
Control 66.36  13.698 67.85  27.870 57.09  14.888 67.50  24.102 66.61  22.418
TB Subjects 43.18  12.044 44.60  32.823 44.06  37.141 45.85  11.236 46.98  23.493
Control 61.26  13.428 62.05  11.122 65.71  23.241 56.71  15.412 52.78  14.271
Schizo Subject 41.22  13.015 53.40  22.813 46.16  37.213 45.39  14.622 43.15  21.533
Control 62.46  12.644 59.06  53.362 62.80  27.378 57.62  16.503 54.91  23.100
HIV Subject 49.23.  13.072 59.63  24.152 52.06  15.345 58.95  14.511 53.15  21.414
Control 67.36  17.614 68.85  38.833 56.09  17.755 63.50  34.107 65.61  29.411
Cancer Subject 41.98  83.062 42.60  74.215 47.06  76.877 45.95  25.837 43.98  84.819
Control 66.46  12.788 67.05  13.362 66.74  28.414 62.62  19.411 64.91  23.744
Dementia Subject 41.70  75.111 45.67  31.075 45.84  91.923 45.33  17.411 47.83  29.384
Control 58.69  13.17 57.28  56.39 58.49  53.44 54.33  29.83 60.62  34.71
Statistical analysis P = 0.001 P = 0.001 P = 0.002 P = 0.004 P = 0.24
DM, diabetes mellitus; HPT, hypertension; HIV, human immunodeficiency virus; TB, tuberculosis; GHF, general health facet.
Table 2.
Quality of life using the WHOQOL-Bref of subjects and controls with diabetes mellitus, hypertension, HIV, tuberculosis, schizophrenia, cancer, and dementia.
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5. Discussion
Young adults from 35 years and above predominated the study group. Similarly,
younger age adults were more prevalent among the HIV, tuberculosis, and schizo-
phrenia groups than the group with hypertension and cancer. The dementia group
was composed of entirely younger age adults. Infectious diseases both sexually and
nonsexually infections were predominantly represented by patients in early adult-
hood [4, 7]. Similarly, tuberculosis is an infective disease, and exposure to it may be
more in adults who work in healthcare facilities and are mostly caregivers close to
already infected persons [7–9]. Tuberculosis is also common in individuals whose
immunity may have waned due to poor nutrition, alcohol use, stress, and other
emotional illnesses, in most times occasioned by the medical illness, as well as other
infective diseases [7–9]. HIV had the most of youngest population with age group
30–39 years forming 60%. This is in line with the earlier finding that HIV is more
prevalent among young persons [24, 27]. Similarly, most cases of schizophrenia
usually begin in early adulthood except paraphrenia that occurs among the elderly
[21]. Hebephrenia, characteristically, one of the most early-onset and worst prog-
noses was excluded the same way as those with AIDS-defined illness that were
excluded among the HIV group. Paranoid schizophrenia was the most common of
the schizophrenic group.
Apart from the influence of genetic predisposition, diabetic mellitus and hyper-
tension are largely a disease of lifestyle including unhealthy eating habits, alcohol
intake, and sedentary lifestyle, which would be mostly displayed among adults
[4, 13, 42, 48–50]. Hypertension is typically a disease of older adults but can occur
in younger ages [12–14]. In this study, the majority of patients with hypertension
were in the 40–49 age group. Cancers can occur in any age group [93–97], and those
in this study ranged from lung, prostate, breast, cervical, blood, and bone cancers to
cancers of the gastrointestinal tract. Dementia is generally a disease of advanced age
but could present as presenile [98–102]. Even though all dementia participants
sampled in this study were within the age group of 40–49, a majority were
presenile. Patients with vascular dementia were excluded to reduce the influence of
high blood pressure on this group. Overall, all the chronic illnesses in this study
span from young to older ages. Therefore the choice of a fairly mid-age as inclusion
criteria for respondents was to reduce the impact of extremes of age on the study
variable particularly quality of life and life span. However, this may have contrib-
uted to the low mortality rate in this study.
In the study, female gender was slightly higher among all subjects with 56%.
Females generally have better healthcare-seeking behavior and tend to have lower
mortality rate at all ages [103]. So, even though hypertension has higher prevalence
in community studies [6, 13, 17], most hospital-based studies show slightly higher
prevalence in females. This is in addition to biological and cultural vulnerability
of HIV infection [104]. Cancer was slightly higher among females, and this could
also be due to the same reason that females report symptoms more readily than do
males [103, 104].
The majority of the respondents were married. However, illnesses that have
predominantly onset in early adulthood like schizophrenia or common among
young adult like HIV had a high percentage of single people [21, 24, 27]. In addition
to being predominant among young people, HIV and schizophrenia are associated
with a high level of stigma [1, 77, 105], although stigma in the former seems to have
reduced significantly over the years. Persons affected with schizophrenia particular
early-onset type tend to have difficulty forming or sustaining relationship or even
get married, and even those who are already married may face a high risk of
separation due to fear of transmission.
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Amajority of the respondents were engaged in middle-class occupation followed
by the lower cadre occupation. Hypertension and dementia which are conditions
seen common in advance age were most common among the first-class occupations,
while cancer, TB, HIV, and schizophrenia were more prevalent among those with
lower cadre occupation. Similarly, about 95% of the respondents fall within low-
and medium-income earners. A rewarding and satisfying job or occupation is key to
good quality of life and by extension prolongs life span [78–84]. Because of the
stigma associated with HIV, tuberculosis, schizophrenia, and to some extent cancer
[1, 105, 106], there is reduced opportunity to secure sustained employment, so most
of these individual settle for menial jobs and petty trading. Even those who had
better jobs are sometimes laid off due to chronic illnesses especially in the private
sector. Diabetes, hypertension and pre-senile dementia, though without risk from
job discrimination, can be the cause of job dissatisfaction due to poor functioning
and performance following disabling symptoms.
The cost of continuing treatment in chronic medical and mental disorders is
usually huge on sufferers and their families [30]. This often is a major reason for
poor drug compliance and in some cases treatment discontinuation [60–62] and
may largely contribute to mortality [51, 58]. A majority of the respondents were
low- and medium-income earners and may have difficulty in financing the
management of their illness. This may reduce quality of life as well as life span.
From the study, the dropout rates were high among dementia patients, followed by
diabetes mellitus and schizophrenia. This may be due to financial difficulty or poor
insight.
Quality of life among all respondents was below average on almost all domains
and was statistically significant on all domains except the general health facet. The
controls all had better quality of life as they all scored above average. Cancer and
tuberculosis patients scored lowest on quality of life particularly both on physical
and psychological domains and on social domains for the later. Apart from specific
symptoms of these two medical conditions, they are usually associated with weight
loss and extreme weakness, and as such the patient may have difficulty carrying out
daily activities. In this case, physical domain of quality of life may be impaired.
Psychological domains of quality of life of people suffering from chronic illnesses
are usually first to be affected [64–73]. Cancers are associated with some level of
stigma but not as high as seen in tuberculosis. The high level of stigma and discrim-
ination associated tuberculosis usually affects the social domain of quality of life
[82, 83, 106, 107]. Diabetes mellitus was the next with poor quality of life especially
on physical and environmental domains, giving credence to a number of studies
[107–110]. Diabetes presents with a lot of physical symptoms and risk of systemic
damage and requires strict drug and dietary compliance. This may have contributed
to the high rate of dropout and poor quality of life.
Hypertension had the best quality of life on all domains followed by HIV. These
two conditions were equally found to have lower crude mortality rates. Generally,
the study found that better quality of life directly correlated with higher person-
years lived and inversely correlated with crude mortality rates (Table 3). Hyper-
tension equally presents with a number of physical symptoms, the risk of systemic
damage, and the need for strict drug compliance. However, it is not associated with
any form of stigma, and a majority of respondents were average-income earners.
The level of stigma and discrimination that was associated with HIV two decades
ago has drastically reduced following massive public awareness. Also, governments
of different countries and the WHO have continued to embark on different inter-
vention strategies including free antiretroviral medications. These effects may have
combined to reduce the financial and social burden including stigma and discrimi-
nation among HIV-positive individuals.
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Quality of life in people living with HIV (PLWHIV), dementia, schizophrenia,
and tuberculosis was significantly affected, more on the psychological and social
domains compared with diabetes mellitus, hypertension, and cancer diseases
[92, 107–112]. This suggests that the stigma and social rejection associated with the
communicable disease may play a significant role in the development of psycholog-
ical illness. This also implies that even though psychological burden is equally
common in the diabetes mellitus and hypertension and affecting quality of life
generally, the presence of psychological burden and trauma that may be associated
with PLWHIV and tuberculosis tended to have more severe negative impact on
quality of life [65, 66]. Again, there is a possibility that there may have been existing
psychological illnesses either undiagnosed or untreated that may have made them
engage in risky sexual behaviors that may have made them vulnerable to infectious
diseases.
The presence of symptoms of tuberculosis, cancers, hypertension, and diabetes
mellitus alone appears to be more disabling than those in PLWHIV, dementia, and
schizophrenia bearing in mind that acute cases were excluded. Moderate to severe
cases of diabetes mellitus, hypertension, and tuberculosis cause more symptoms,
and they are more disabling. This may account for the better quality of life among
PLWHIV on the physical domain and the lower quality of life scores on both the
physical and environment domains, among them, than the PLWHIV in this study.
HIV not complicated with AIDS is most of the time symptom free or stable on
medication, and this stability is often less sensitive to adverse environmental factors
unlike in diabetes mellitus, hypertension, and tuberculosis where little adverse
changes in the environment could affect profoundly the patients who had hitherto
remained stable on medications [12, 22, 30, 39, 43, 52]. Such changes may include
change in income level, employment, marital status (prolonged difficulty, dishar-
mony, separation, divorce, or widowhood), and poor drug adherence with imme-
diate exacerbation of symptoms.
A majority of the patients in all medical conditions fared well on most domains.
The possible reasons are their focus on physical strength (e.g., evident physical
health, absence of symptoms, ability to work around, available family support, and
a strong religious belief) than on their weaknesses (e.g., social discrimination). On
Domains 1 and 4, PLWHIV had better performance on quality of life, followed by
hypertension and diabetes mellitus, while tuberculosis had the least in similar
domains. Furthermore, PLWHIV also scored higher on GHF than the other medical
conditions.
Condition No. of alive at
beginning of
study
Average
quality of life
No. of
deaths
Dropout Mean
person-
years lived
Crude
mortality
rate
Hypertension 20 49.84  26.124 2 (10%) 1 (5%) 2.31 0.844
Diabetes 20 45.31  71.012 3 (15%) 2 (10%) 2.15 1.395
Tuberculosis 20 41.92  13.021 4 (20%) 0 (0%) 1.21 3.306
Schizophrenia 20 53.43  22.081 1 (5%) 2 (10%) 3.42 0.292
HIV 20 47.51  31.411 2 (10%) 1 (5%) 2.83 0.707
Cancer 20 42.61  78.033 4 (20%) 1 (5%) 1.85 2.162
Dementia 20 48.19  85.151 2 (10%) 3 (15%) 3.21 0.623
Control 35 67.22  52.81 0 (0%) 1 (5%) — —
Table 3.
Record of death and survival of respondents.
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Chronic medical and mental diseases account for multiple burdens for patients,
including the necessity to deal with pain, suffering, reduced quality of life, prema-
ture mortality, financial costs, and familial emotional trauma [12, 30, 32, 72, 73].
The risk factors for mental health problems among patients suffering from chronic
medical illnesses are complex [72, 73, 113]. Usually, the more serious the somatic
disease and symptoms are, the more probable it will be to be accompanied by mood
and/or anxiety symptoms of variable severity [72, 73]; conditions arising after the
somatic disease are diagnosed. In other words, even if those with dual diagnoses
were excluded from the study, it clearly understood that most chronic medical
conditions tend to be associated with some emotional disturbance. Failure to man-
age such mental health problems increases the patients’ probability of suffering
from complications, even lethal.
In chronic medical conditions, functionality may be severely impaired due to
chronic psychogenic and somatic pain, frequent hospital admissions, and depen-
dency from medical and nursing personnel. These are all markers of poor quality of
life and well-being. It is important to mention that most of the mortalities in chronic
medical conditions may not be due to the direct complication of the disease, rather a
cumulative outcome of social and psychological dissatisfaction of the condition.
Sufferers maintain the feeling that they have come to the end of the road and seek
the easiest escape rooting out of the problem which is suicide [114–117]. In addition,
research has pointed out a relationship between sustained emotional disturbance
especially depression and reduced immunity. This may be worse among chronically
ill patients, and this makes them more vulnerable to recurrent infections or rein-
fections. Good quality of life and well-being are a measure of satisfaction in major
areas of life including mood stability and affording basic nutrition which will
sustain immunity.
Most chronic illnesses particularly HIV, cancer, and tuberculosis in sub-Saharan
Africa are classic examples of diseases with both medical and social dimensions,
characterized by its close relation to poor socioeconomic conditions [27–31]. For
instance, in tuberculosis, a higher risk of acquiring active disease occurs with alco-
holism, smoking [48, 49], intravenous drug abuse [48, 49, 58, 74], diabetes
mellitus, HIV infection, overcrowding, and other factors. The abovementioned
risk factors are very prevalent among populations with reduced quality of life and
well-being and increase risk of having HIV and progression from latent TB to
active TB [77].
From the study, mortality was the highest among tuberculosis and cancer
patients, followed by patients with diabetes mellitus. Schizophrenia had the lowest
mortality after 5 years. There was no mortality among the control within the period.
Correspondingly, mortally was the highest among the groups with the lowest qual-
ity of life. Quality of life is an indicator of total well-being and optimal health;
therefore, if it is low, then it is an indication that the individual may not be enjoying
good health. The finding among the diabetes group is in line with the earlier report
that reduced life expectancy at age 15 by 1.3 years for men and 2.0 years for women
in Canada [47] and a BMI of 40–45 kg/m2 were associated with a 10-year reduction
of life expectancy at age 35 compared to a BMI of 22.5–25 kg/m2 [118]. Causes of
mortality may be due to organ damage, complication of medication, systemic dam-
age, or hemodynamic changes. Actual or direct causes of the deaths could not be
ascertained as many of the deaths did not occur in the hospital. Mortality from
tuberculosis and cancer tends to be high with a low rate of survival. Mortality in
severe chronic mental illness is recognized to be raised, and underlying causes may
be multiple. However, the death rate was lowest among schizophrenics in this
study. This may be due to the fact the schizophrenics were predominantly young
12
Aging - Life Span and Life Expectancy
population and also because those with poor prognosis like hebephrenia and
disorganized were excluded from the study and only paranoid and catatonic types
which carry better prognosis were included. This finding however differs from the
earlier finding that any psychiatric diagnosis was associated with a 65% higher
than expected total mortality in a case register study in a British primary care
cohort [119].
Coronary heart disease accounts for threefold elevated mortality in young adults
with severe mental illness [120] and diabetes, while stroke is usually a complication
of long-standing hypertension. Long-term antipsychotic use and adverse lifestyle
choices (e.g., obesity, smoking, poor diet, illicit drug use, and physical inactivity)
are implicated in increased risk of cardiovascular events in these populations [1, 51,
120–122] and clearly need higher levels of consideration in order to improve health
and survival, as well as the better-known risks of suicide and violent deaths. The
causal pathways between mental disorder and premature mortality are multiple,
making life years lost an important outcome measure in this population.
Life expectancy is a commonly used indicator for how longevity may be
impaired by specific long-term exposures (e.g., smoking, obesity, ethnicity, and
socioeconomic status) or chronic conditions of ill health or risk (e.g., diabetes
mellitus) [48, 49] and provides an alternative measure to determine the influences
of different exposures for the purpose of highlighting premature mortality at youn-
ger ages in potentially vulnerable groups. It is therefore primarily a measure of
impact and should be seen as complementary to more elaborate studies using mea-
sures of effect. As a measure, life expectancy analyses offer an important means of
communicating impact on survival to policy makers. Current smoking is associated
with around 4 to 5 life years lost for both genders [48, 49].
Clearly the mechanisms through which medical and mental disorders are asso-
ciated with premature mortality will include the effects of these individual risk
factors (e.g., smoking behavior, risk of diabetes, etc.) as well as other factors (such
as risk of suicide or accidents and direct effects of mental distress on cardiovascular
risk). Excess mortality associated with mental disorders has been demonstrated to
be predominantly due to “natural” causes [18, 119, 120] although mental health
service provision is often focused on preventing more rare outcomes of suicide and
violent death [115–117]. If improving overall survival is to be considered as an
alternative priority, much more efforts are clearly required to address the chal-
lenges of improving general health in people with mental disorders through medical
services, socioeconomic support, and physical health promotion strategies [51].
It is important to note that a good number of psychosocial and clinical factors,
like increased age, marital status (married), later age of onset of illness, education,
employment, average to high monthly income, shorter duration of illness, longer
duration of treatment, and emotional stability, may affect the quality of life and
other outcome of the medical conditions. The implication of this is that these factors
have to be addressed in the holistic management of these and indeed other chronic
medical conditions.
6. Conclusion
The findings of this study support the impression that chronic medical condi-
tions are associated with reduced quality of life, which, together with a number of
sociodemographic and clinical factors, in turn affect life expectancy. The results
support the call that the management of patients with these medical conditions
should necessarily include attention to the mental health status of the sufferers.
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7. Recommendations
Based on the findings of this study that chronic medical conditions are com-
monly associated with reduced quality of life and well-being, which further affect
longevity, it becomes imperative that renewed efforts by government, aimed at
both primary and secondary prevention, be intensified for these chronic medical
conditions.
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